Cholangiocarcinoma cell-derived ExVs inhibited the antitumor activity of cytokine-induced NK cells by down-regulating the population of CD3+, CD8+, CD56+ and CD3+CD56+cells and the secretion of TNF-α and perforin. This evidence concerns the gene NCAM1 and cholangiocarcinoma.